GE HealthCare Starts Class II Recall of Centricity PACS Software

GE HealthCare initiated a voluntary Class II recall of its Centricity PACS imaging software worldwide, according to Yahoo News, citing a late-September report from the US FDA.

The recall concerns a condition in which migrated historical imaging data could be linked to the wrong patient. Yahoo News reported that the issue could potentially contribute to misdiagnosis or delayed care.

Recall scope and reported issue

The US FDA report covered 1,443 systems, according to Yahoo News. The issue was identified in certain conditions involving migrated historical imaging data within the Centricity PACS imaging software.

For medical sales professionals working with imaging, informatics, and clinical workflow customers, the event places attention on patient-data integrity during software migration and on the operational processes surrounding imaging records.

Commercial context for GE HealthCare

Yahoo News reported that the recall occurred in the same week GE HealthCare announced a 14% increase in its quarterly dividend to US$0.04 per share.

The publisher also noted the planned addition of experienced leadership, though the supplied report did not provide further detail. The recall remains the central clinical and technology event, with the FDA-reported classification and worldwide scope framing customer discussions around imaging software management.

Key points for sales conversations

• Product area: Centricity PACS imaging software.
• Regulatory status: Voluntary Class II recall reported by the US FDA.
• Reported concern: Historical migrated imaging data could be associated with the wrong patient under certain conditions.
• Reported scope: 1,443 systems worldwide.

Yahoo News attributed the information to the US FDA’s late-September report. Professionals should distinguish the reported software issue from broader imaging technology discussions and keep customer communications aligned with the recall information available through official channels.